nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ALB—lung cancer	0.00232	0.363	CrCbGaD
Remifentanil—Alfentanil—ABCB1—lung cancer	0.00221	0.347	CrCbGaD
Remifentanil—Pethidine—ALB—lung cancer	0.00104	0.164	CrCbGaD
Remifentanil—Fentanyl—ABCB1—lung cancer	0.000809	0.127	CrCbGaD
Remifentanil—Hypertension—Paclitaxel—lung cancer	0.00068	0.000717	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000679	0.000716	CcSEcCtD
Remifentanil—Pruritus—Vinorelbine—lung cancer	0.000676	0.000713	CcSEcCtD
Remifentanil—Pain—Irinotecan—lung cancer	0.000674	0.000711	CcSEcCtD
Remifentanil—Constipation—Irinotecan—lung cancer	0.000674	0.000711	CcSEcCtD
Remifentanil—Hypotension—Cisplatin—lung cancer	0.000668	0.000705	CcSEcCtD
Remifentanil—Anxiety—Paclitaxel—lung cancer	0.000668	0.000705	CcSEcCtD
Remifentanil—Erythema—Docetaxel—lung cancer	0.000667	0.000704	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000666	0.000702	CcSEcCtD
Remifentanil—Nausea—Topotecan—lung cancer	0.000663	0.0007	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000662	0.000699	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—lung cancer	0.000662	0.000698	CcSEcCtD
Remifentanil—Confusional state—Etoposide—lung cancer	0.000661	0.000697	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—lung cancer	0.000657	0.000694	CcSEcCtD
Remifentanil—Pain—Gemcitabine—lung cancer	0.000656	0.000692	CcSEcCtD
Remifentanil—Constipation—Gemcitabine—lung cancer	0.000656	0.000692	CcSEcCtD
Remifentanil—Nausea—Erlotinib—lung cancer	0.000656	0.000692	CcSEcCtD
Remifentanil—Dry mouth—Paclitaxel—lung cancer	0.000655	0.000691	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—lung cancer	0.000655	0.000691	CcSEcCtD
Remifentanil—Diarrhoea—Vinorelbine—lung cancer	0.000653	0.000689	CcSEcCtD
Remifentanil—Feeling abnormal—Irinotecan—lung cancer	0.000649	0.000685	CcSEcCtD
Remifentanil—Confusional state—Paclitaxel—lung cancer	0.000648	0.000683	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—lung cancer	0.000645	0.000681	CcSEcCtD
Remifentanil—Anaphylactic shock—Paclitaxel—lung cancer	0.000642	0.000678	CcSEcCtD
Remifentanil—Oedema—Paclitaxel—lung cancer	0.000642	0.000678	CcSEcCtD
Remifentanil—Paraesthesia—Cisplatin—lung cancer	0.000642	0.000678	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—lung cancer	0.000641	0.000677	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—lung cancer	0.000639	0.000675	CcSEcCtD
Remifentanil—Dyspnoea—Cisplatin—lung cancer	0.000638	0.000673	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—lung cancer	0.000636	0.000671	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—lung cancer	0.000633	0.000668	CcSEcCtD
Remifentanil—Feeling abnormal—Gemcitabine—lung cancer	0.000632	0.000667	CcSEcCtD
Remifentanil—Shock—Paclitaxel—lung cancer	0.000632	0.000667	CcSEcCtD
Remifentanil—Dizziness—Vinorelbine—lung cancer	0.000632	0.000666	CcSEcCtD
Remifentanil—Nervous system disorder—Paclitaxel—lung cancer	0.00063	0.000665	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—lung cancer	0.000629	0.000664	CcSEcCtD
Remifentanil—Thrombocytopenia—Paclitaxel—lung cancer	0.000629	0.000664	CcSEcCtD
Remifentanil—Tachycardia—Paclitaxel—lung cancer	0.000627	0.000661	CcSEcCtD
Remifentanil—Skin disorder—Paclitaxel—lung cancer	0.000624	0.000658	CcSEcCtD
Remifentanil—Body temperature increased—Irinotecan—lung cancer	0.000623	0.000657	CcSEcCtD
Remifentanil—Hyperhidrosis—Paclitaxel—lung cancer	0.000621	0.000655	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—lung cancer	0.000619	0.000653	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—lung cancer	0.000618	0.000652	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Cisplatin—lung cancer	0.000617	0.000651	CcSEcCtD
Remifentanil—Anaemia—Docetaxel—lung cancer	0.000617	0.000651	CcSEcCtD
Remifentanil—Hypotension—Etoposide—lung cancer	0.000612	0.000646	CcSEcCtD
Remifentanil—Pain—Cisplatin—lung cancer	0.000612	0.000645	CcSEcCtD
Remifentanil—Vomiting—Vinorelbine—lung cancer	0.000607	0.000641	CcSEcCtD
Remifentanil—Body temperature increased—Gemcitabine—lung cancer	0.000607	0.00064	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—lung cancer	0.000605	0.000638	CcSEcCtD
Remifentanil—Rash—Vinorelbine—lung cancer	0.000602	0.000635	CcSEcCtD
Remifentanil—Dermatitis—Vinorelbine—lung cancer	0.000602	0.000635	CcSEcCtD
Remifentanil—Hypotension—Paclitaxel—lung cancer	0.0006	0.000633	CcSEcCtD
Remifentanil—Headache—Vinorelbine—lung cancer	0.000598	0.000631	CcSEcCtD
Remifentanil—Syncope—Docetaxel—lung cancer	0.000598	0.000631	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—lung cancer	0.000598	0.00063	CcSEcCtD
Remifentanil—Sweating—Methotrexate—lung cancer	0.00059	0.000622	CcSEcCtD
Remifentanil—Feeling abnormal—Cisplatin—lung cancer	0.000589	0.000622	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—lung cancer	0.000588	0.000621	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—lung cancer	0.000587	0.000619	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—lung cancer	0.000586	0.000619	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—lung cancer	0.000584	0.000616	CcSEcCtD
Remifentanil—Somnolence—Etoposide—lung cancer	0.000582	0.000615	CcSEcCtD
Remifentanil—Cough—Docetaxel—lung cancer	0.000582	0.000614	CcSEcCtD
Remifentanil—Hypersensitivity—Irinotecan—lung cancer	0.00058	0.000612	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—lung cancer	0.000578	0.00061	CcSEcCtD
Remifentanil—Paraesthesia—Paclitaxel—lung cancer	0.000577	0.000609	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—lung cancer	0.000576	0.000608	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—lung cancer	0.000575	0.000606	CcSEcCtD
Remifentanil—Dyspnoea—Paclitaxel—lung cancer	0.000573	0.000604	CcSEcCtD
Remifentanil—Somnolence—Paclitaxel—lung cancer	0.000571	0.000603	CcSEcCtD
Remifentanil—Nausea—Vinorelbine—lung cancer	0.000567	0.000599	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—lung cancer	0.000566	0.000597	CcSEcCtD
Remifentanil—Dyspepsia—Paclitaxel—lung cancer	0.000565	0.000597	CcSEcCtD
Remifentanil—Body temperature increased—Cisplatin—lung cancer	0.000565	0.000596	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000564	0.000595	CcSEcCtD
Remifentanil—Pain—Etoposide—lung cancer	0.00056	0.000591	CcSEcCtD
Remifentanil—Constipation—Etoposide—lung cancer	0.00056	0.000591	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—lung cancer	0.000559	0.00059	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—lung cancer	0.000555	0.000586	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—lung cancer	0.000555	0.000586	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000555	0.000585	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—lung cancer	0.000552	0.000583	CcSEcCtD
Remifentanil—Constipation—Paclitaxel—lung cancer	0.000549	0.00058	CcSEcCtD
Remifentanil—Pain—Paclitaxel—lung cancer	0.000549	0.00058	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—lung cancer	0.000549	0.000579	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—lung cancer	0.000548	0.000578	CcSEcCtD
Remifentanil—Oedema—Docetaxel—lung cancer	0.000544	0.000574	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—lung cancer	0.000544	0.000574	CcSEcCtD
Remifentanil—Pruritus—Gemcitabine—lung cancer	0.000543	0.000573	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—lung cancer	0.00054	0.00057	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—lung cancer	0.000539	0.000569	CcSEcCtD
Remifentanil—Diarrhoea—Irinotecan—lung cancer	0.000539	0.000569	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—lung cancer	0.000536	0.000565	CcSEcCtD
Remifentanil—Shock—Docetaxel—lung cancer	0.000536	0.000565	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—lung cancer	0.000534	0.000563	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—lung cancer	0.000533	0.000562	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—lung cancer	0.000532	0.000562	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—lung cancer	0.000531	0.000561	CcSEcCtD
Remifentanil—Feeling abnormal—Paclitaxel—lung cancer	0.000529	0.000558	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—lung cancer	0.000529	0.000558	CcSEcCtD
Remifentanil—Hypersensitivity—Cisplatin—lung cancer	0.000527	0.000556	CcSEcCtD
Remifentanil—Diarrhoea—Gemcitabine—lung cancer	0.000525	0.000554	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—lung cancer	0.000524	0.000553	CcSEcCtD
Remifentanil—Dizziness—Irinotecan—lung cancer	0.000521	0.00055	CcSEcCtD
Remifentanil—Urticaria—Etoposide—lung cancer	0.00052	0.000549	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—lung cancer	0.000518	0.000546	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—lung cancer	0.000513	0.000541	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—lung cancer	0.000511	0.000539	CcSEcCtD
Remifentanil—Urticaria—Paclitaxel—lung cancer	0.00051	0.000538	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—lung cancer	0.000509	0.000537	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—lung cancer	0.000508	0.000536	CcSEcCtD
Remifentanil—Body temperature increased—Paclitaxel—lung cancer	0.000508	0.000536	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—lung cancer	0.000501	0.000529	CcSEcCtD
Remifentanil—Vomiting—Irinotecan—lung cancer	0.000501	0.000528	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—lung cancer	0.000499	0.000526	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—lung cancer	0.000498	0.000525	CcSEcCtD
Remifentanil—Rash—Irinotecan—lung cancer	0.000497	0.000524	CcSEcCtD
Remifentanil—Dermatitis—Irinotecan—lung cancer	0.000496	0.000523	CcSEcCtD
Remifentanil—Chills—Methotrexate—lung cancer	0.000496	0.000523	CcSEcCtD
Remifentanil—Headache—Irinotecan—lung cancer	0.000493	0.000521	CcSEcCtD
Remifentanil—Diarrhoea—Cisplatin—lung cancer	0.000489	0.000516	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—lung cancer	0.000489	0.000516	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—lung cancer	0.000488	0.000515	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—lung cancer	0.000487	0.000514	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—lung cancer	0.000485	0.000512	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—lung cancer	0.000484	0.000511	CcSEcCtD
Remifentanil—Rash—Gemcitabine—lung cancer	0.000484	0.00051	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—lung cancer	0.000483	0.00051	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—lung cancer	0.000483	0.000509	CcSEcCtD
Remifentanil—Erythema—Methotrexate—lung cancer	0.000481	0.000507	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—lung cancer	0.000481	0.000507	CcSEcCtD
Remifentanil—Headache—Gemcitabine—lung cancer	0.000481	0.000507	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—lung cancer	0.000479	0.000506	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—lung cancer	0.000478	0.000505	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—lung cancer	0.000475	0.000501	CcSEcCtD
Remifentanil—Hypersensitivity—Paclitaxel—lung cancer	0.000473	0.000499	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—lung cancer	0.00047	0.000496	CcSEcCtD
Remifentanil—Nausea—Irinotecan—lung cancer	0.000468	0.000494	CcSEcCtD
Remifentanil—Pain—Docetaxel—lung cancer	0.000466	0.000491	CcSEcCtD
Remifentanil—Constipation—Docetaxel—lung cancer	0.000466	0.000491	CcSEcCtD
Remifentanil—Pruritus—Etoposide—lung cancer	0.000464	0.000489	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—lung cancer	0.000461	0.000486	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—lung cancer	0.000456	0.000481	CcSEcCtD
Remifentanil—Vomiting—Cisplatin—lung cancer	0.000455	0.00048	CcSEcCtD
Remifentanil—Pruritus—Paclitaxel—lung cancer	0.000454	0.000479	CcSEcCtD
Remifentanil—Rash—Cisplatin—lung cancer	0.000451	0.000476	CcSEcCtD
Remifentanil—Dermatitis—Cisplatin—lung cancer	0.000451	0.000475	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—lung cancer	0.000449	0.000473	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—lung cancer	0.000448	0.000473	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—lung cancer	0.000444	0.000469	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—lung cancer	0.000444	0.000468	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—lung cancer	0.000444	0.000468	CcSEcCtD
Remifentanil—Diarrhoea—Paclitaxel—lung cancer	0.00044	0.000464	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—lung cancer	0.000434	0.000458	CcSEcCtD
Remifentanil—Dizziness—Etoposide—lung cancer	0.000433	0.000457	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—lung cancer	0.000432	0.000456	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—lung cancer	0.000431	0.000455	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—lung cancer	0.00043	0.000454	CcSEcCtD
Remifentanil—Chills—Doxorubicin—lung cancer	0.000429	0.000453	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—lung cancer	0.000427	0.000451	CcSEcCtD
Remifentanil—Dizziness—Paclitaxel—lung cancer	0.000425	0.000448	CcSEcCtD
Remifentanil—Nausea—Cisplatin—lung cancer	0.000425	0.000448	CcSEcCtD
Remifentanil—Cough—Methotrexate—lung cancer	0.00042	0.000443	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—lung cancer	0.000417	0.00044	CcSEcCtD
Remifentanil—Vomiting—Etoposide—lung cancer	0.000417	0.000439	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—lung cancer	0.000416	0.000439	CcSEcCtD
Remifentanil—Rash—Etoposide—lung cancer	0.000413	0.000436	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—lung cancer	0.000413	0.000435	CcSEcCtD
Remifentanil—Headache—Etoposide—lung cancer	0.00041	0.000433	CcSEcCtD
Remifentanil—Vomiting—Paclitaxel—lung cancer	0.000408	0.000431	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000407	0.000429	CcSEcCtD
Remifentanil—Rash—Paclitaxel—lung cancer	0.000405	0.000427	CcSEcCtD
Remifentanil—Dermatitis—Paclitaxel—lung cancer	0.000405	0.000427	CcSEcCtD
Remifentanil—Headache—Paclitaxel—lung cancer	0.000402	0.000425	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—lung cancer	0.000401	0.000423	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—lung cancer	0.000396	0.000417	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—lung cancer	0.000392	0.000414	CcSEcCtD
Remifentanil—Nausea—Etoposide—lung cancer	0.000389	0.000411	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—lung cancer	0.000385	0.000406	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—lung cancer	0.000385	0.000406	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—lung cancer	0.000385	0.000406	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—lung cancer	0.000384	0.000405	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—lung cancer	0.000383	0.000404	CcSEcCtD
Remifentanil—Nausea—Paclitaxel—lung cancer	0.000382	0.000403	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—lung cancer	0.000381	0.000402	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—lung cancer	0.000379	0.0004	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—lung cancer	0.000373	0.000394	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—lung cancer	0.000373	0.000393	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—lung cancer	0.000367	0.000387	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—lung cancer	0.000366	0.000386	CcSEcCtD
Remifentanil—Cough—Doxorubicin—lung cancer	0.000363	0.000383	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—lung cancer	0.000361	0.000381	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—lung cancer	0.00036	0.00038	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—lung cancer	0.000359	0.000379	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—lung cancer	0.000353	0.000373	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—lung cancer	0.000352	0.000372	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000352	0.000371	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—lung cancer	0.00035	0.000369	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—lung cancer	0.000349	0.000368	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—lung cancer	0.000347	0.000366	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—lung cancer	0.000346	0.000365	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—lung cancer	0.000345	0.000364	CcSEcCtD
Remifentanil—Rash—Docetaxel—lung cancer	0.000343	0.000362	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—lung cancer	0.000343	0.000362	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—lung cancer	0.000343	0.000361	CcSEcCtD
Remifentanil—Headache—Docetaxel—lung cancer	0.000341	0.00036	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—lung cancer	0.00034	0.000359	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—lung cancer	0.00034	0.000359	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—lung cancer	0.000339	0.000357	CcSEcCtD
Remifentanil—Pain—Methotrexate—lung cancer	0.000336	0.000354	CcSEcCtD
Remifentanil—Shock—Doxorubicin—lung cancer	0.000334	0.000353	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—lung cancer	0.000333	0.000352	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—lung cancer	0.000333	0.000351	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—lung cancer	0.000332	0.00035	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—lung cancer	0.00033	0.000348	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—lung cancer	0.000329	0.000347	CcSEcCtD
Remifentanil—Nausea—Docetaxel—lung cancer	0.000323	0.000341	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—lung cancer	0.000323	0.000341	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—lung cancer	0.000318	0.000335	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—lung cancer	0.000312	0.000329	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—lung cancer	0.00031	0.000327	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—lung cancer	0.000305	0.000322	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—lung cancer	0.000303	0.00032	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—lung cancer	0.000302	0.000319	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—lung cancer	0.000299	0.000316	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000293	0.00031	CcSEcCtD
Remifentanil—Pain—Doxorubicin—lung cancer	0.000291	0.000307	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—lung cancer	0.000291	0.000307	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—lung cancer	0.000289	0.000305	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—lung cancer	0.00028	0.000295	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—lung cancer	0.000278	0.000293	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—lung cancer	0.00027	0.000285	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—lung cancer	0.000269	0.000283	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—lung cancer	0.000269	0.000283	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—lung cancer	0.00026	0.000274	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—lung cancer	0.00025	0.000264	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—lung cancer	0.00025	0.000263	CcSEcCtD
Remifentanil—Rash—Methotrexate—lung cancer	0.000247	0.000261	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—lung cancer	0.000247	0.000261	CcSEcCtD
Remifentanil—Headache—Methotrexate—lung cancer	0.000246	0.000259	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—lung cancer	0.00024	0.000254	CcSEcCtD
Remifentanil—Nausea—Methotrexate—lung cancer	0.000233	0.000246	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—lung cancer	0.000233	0.000245	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—lung cancer	0.000225	0.000237	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—lung cancer	0.000216	0.000228	CcSEcCtD
Remifentanil—Rash—Doxorubicin—lung cancer	0.000214	0.000226	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—lung cancer	0.000214	0.000226	CcSEcCtD
Remifentanil—Headache—Doxorubicin—lung cancer	0.000213	0.000225	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—lung cancer	0.000202	0.000213	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—ANXA1—lung cancer	5.17e-05	0.00113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP2R1B—lung cancer	5.06e-05	0.00111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SMARCA4—lung cancer	5.06e-05	0.00111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FLT1—lung cancer	5.01e-05	0.00109	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CG—lung cancer	4.96e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APP—lung cancer	4.9e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH3—lung cancer	4.9e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HSPB1—lung cancer	4.88e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNG11—lung cancer	4.88e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF9—lung cancer	4.86e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTHLH—lung cancer	4.83e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—lung cancer	4.79e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AVP—lung cancer	4.79e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—POMC—lung cancer	4.73e-05	0.00103	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFC—lung cancer	4.65e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUNB—lung cancer	4.64e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ANXA1—lung cancer	4.54e-05	0.000991	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CG—lung cancer	4.51e-05	0.000985	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FLT1—lung cancer	4.39e-05	0.00096	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADCY1—lung cancer	4.39e-05	0.000958	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CD—lung cancer	4.36e-05	0.000953	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CG—lung cancer	4.35e-05	0.000951	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APP—lung cancer	4.3e-05	0.00094	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH3—lung cancer	4.3e-05	0.00094	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—POMC—lung cancer	4.29e-05	0.000937	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SMARCA4—lung cancer	4.27e-05	0.000934	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	4.27e-05	0.000934	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF9—lung cancer	4.27e-05	0.000932	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STK11—lung cancer	4.22e-05	0.000921	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6R—lung cancer	4.19e-05	0.000914	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—lung cancer	4.14e-05	0.000905	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HSPB1—lung cancer	4.12e-05	0.000901	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTHLH—lung cancer	4.08e-05	0.000891	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUNB—lung cancer	4.07e-05	0.00089	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FOXO3—lung cancer	4.07e-05	0.000889	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAP2K1—lung cancer	3.99e-05	0.000872	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CD—lung cancer	3.96e-05	0.000866	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—lung cancer	3.95e-05	0.000864	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ANXA1—lung cancer	3.83e-05	0.000838	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CD—lung cancer	3.83e-05	0.000836	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AVP—lung cancer	3.81e-05	0.000833	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CB—lung cancer	3.8e-05	0.000831	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—lung cancer	3.76e-05	0.000822	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FLT1—lung cancer	3.71e-05	0.000811	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STK11—lung cancer	3.7e-05	0.000808	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	3.68e-05	0.000804	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1R—lung cancer	3.67e-05	0.000802	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6R—lung cancer	3.67e-05	0.000802	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—lung cancer	3.66e-05	0.000799	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APP—lung cancer	3.63e-05	0.000794	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH3—lung cancer	3.63e-05	0.000794	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HES1—lung cancer	3.61e-05	0.000788	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF9—lung cancer	3.6e-05	0.000788	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FOXO3—lung cancer	3.57e-05	0.00078	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RAF1—lung cancer	3.54e-05	0.000773	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—lung cancer	3.5e-05	0.000765	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	3.5e-05	0.000764	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—lung cancer	3.49e-05	0.000763	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	3.47e-05	0.000759	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	3.45e-05	0.000755	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUNB—lung cancer	3.44e-05	0.000752	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AVP—lung cancer	3.34e-05	0.000731	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	3.34e-05	0.00073	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	3.34e-05	0.000729	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—lung cancer	3.32e-05	0.000725	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB3—lung cancer	3.3e-05	0.00072	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	3.23e-05	0.000707	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1R—lung cancer	3.22e-05	0.000703	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	3.21e-05	0.0007	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—lung cancer	3.18e-05	0.000695	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—lung cancer	3.17e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—lung cancer	3.16e-05	0.000691	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—lung cancer	3.16e-05	0.000691	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STK11—lung cancer	3.13e-05	0.000683	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RAF1—lung cancer	3.1e-05	0.000678	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6R—lung cancer	3.1e-05	0.000678	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR1—lung cancer	3.07e-05	0.00067	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—lung cancer	3.06e-05	0.000669	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	3.03e-05	0.000662	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—lung cancer	3.02e-05	0.00066	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FOXO3—lung cancer	3.02e-05	0.000659	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	2.96e-05	0.000646	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	2.94e-05	0.000642	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—lung cancer	2.92e-05	0.000637	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—lung cancer	2.91e-05	0.000636	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB3—lung cancer	2.89e-05	0.000632	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—lung cancer	2.89e-05	0.000632	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AVP—lung cancer	2.83e-05	0.000618	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	2.82e-05	0.000616	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—lung cancer	2.78e-05	0.000608	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—lung cancer	2.77e-05	0.000605	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1R—lung cancer	2.72e-05	0.000594	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	2.71e-05	0.000592	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR1—lung cancer	2.69e-05	0.000588	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—lung cancer	2.67e-05	0.000584	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—lung cancer	2.66e-05	0.000582	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KIT—lung cancer	2.66e-05	0.000582	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APC—lung cancer	2.66e-05	0.000582	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NRAS—lung cancer	2.66e-05	0.000582	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—lung cancer	2.65e-05	0.000579	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGF—lung cancer	2.63e-05	0.000575	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAF1—lung cancer	2.62e-05	0.000573	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—lung cancer	2.59e-05	0.000566	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	2.56e-05	0.000559	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—lung cancer	2.56e-05	0.000559	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—lung cancer	2.55e-05	0.000557	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—lung cancer	2.53e-05	0.000554	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—lung cancer	2.53e-05	0.000554	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BRAF—lung cancer	2.5e-05	0.000547	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6R—lung cancer	2.47e-05	0.00054	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CREBBP—lung cancer	2.47e-05	0.000539	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—lung cancer	2.46e-05	0.000537	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB3—lung cancer	2.44e-05	0.000534	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—lung cancer	2.43e-05	0.00053	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAP2K1—lung cancer	2.36e-05	0.000515	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—lung cancer	2.35e-05	0.000514	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—lung cancer	2.34e-05	0.000512	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—lung cancer	2.34e-05	0.000511	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APC—lung cancer	2.34e-05	0.00051	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIT—lung cancer	2.34e-05	0.00051	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—lung cancer	2.34e-05	0.00051	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NRAS—lung cancer	2.33e-05	0.00051	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	2.32e-05	0.000507	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGF—lung cancer	2.31e-05	0.000504	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—lung cancer	2.29e-05	0.000501	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR1—lung cancer	2.27e-05	0.000497	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—lung cancer	2.24e-05	0.000489	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—lung cancer	2.24e-05	0.000489	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—lung cancer	2.22e-05	0.000486	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BRAF—lung cancer	2.19e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6R—lung cancer	2.17e-05	0.000474	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CREBBP—lung cancer	2.16e-05	0.000473	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—lung cancer	2.16e-05	0.000472	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—lung cancer	2.14e-05	0.000468	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—lung cancer	2.13e-05	0.000465	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	2.11e-05	0.00046	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MDM2—lung cancer	2.1e-05	0.000458	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAF1—lung cancer	2.09e-05	0.000457	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB2—lung cancer	2.07e-05	0.000452	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAP2K1—lung cancer	2.07e-05	0.000451	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—lung cancer	2.05e-05	0.000448	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTOR—lung cancer	2.04e-05	0.000446	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—lung cancer	2.04e-05	0.000446	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	2.03e-05	0.000444	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—lung cancer	2.01e-05	0.000439	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APC—lung cancer	1.97e-05	0.000431	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—lung cancer	1.97e-05	0.000431	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIT—lung cancer	1.97e-05	0.000431	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NRAS—lung cancer	1.97e-05	0.000431	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—lung cancer	1.96e-05	0.000428	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGF—lung cancer	1.95e-05	0.000426	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—lung cancer	1.95e-05	0.000426	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—lung cancer	1.89e-05	0.000414	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—lung cancer	1.89e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—lung cancer	1.88e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—lung cancer	1.88e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—lung cancer	1.87e-05	0.000409	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—lung cancer	1.86e-05	0.000407	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BRAF—lung cancer	1.85e-05	0.000405	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	1.85e-05	0.000403	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MDM2—lung cancer	1.84e-05	0.000402	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAF1—lung cancer	1.83e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6R—lung cancer	1.83e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CREBBP—lung cancer	1.83e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—lung cancer	1.83e-05	0.000399	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUN—lung cancer	1.82e-05	0.000398	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB2—lung cancer	1.81e-05	0.000396	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—lung cancer	1.8e-05	0.000393	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTOR—lung cancer	1.79e-05	0.000391	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—lung cancer	1.79e-05	0.000391	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—lung cancer	1.77e-05	0.000387	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1A—lung cancer	1.77e-05	0.000386	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—lung cancer	1.76e-05	0.000385	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAP2K1—lung cancer	1.75e-05	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—lung cancer	1.73e-05	0.000379	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—lung cancer	1.72e-05	0.000376	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—lung cancer	1.72e-05	0.000376	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.72e-05	0.000375	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—lung cancer	1.71e-05	0.000373	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—lung cancer	1.7e-05	0.000371	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EP300—lung cancer	1.68e-05	0.000367	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—lung cancer	1.66e-05	0.000363	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—lung cancer	1.65e-05	0.00036	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—lung cancer	1.64e-05	0.000359	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—lung cancer	1.64e-05	0.000357	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—lung cancer	1.63e-05	0.000357	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—lung cancer	1.6e-05	0.00035	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUN—lung cancer	1.6e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—lung cancer	1.59e-05	0.000348	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—lung cancer	1.58e-05	0.000345	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NRAS—lung cancer	1.57e-05	0.000344	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	1.56e-05	0.000341	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—lung cancer	1.56e-05	0.00034	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MDM2—lung cancer	1.55e-05	0.00034	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1A—lung cancer	1.55e-05	0.000339	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAF1—lung cancer	1.55e-05	0.000338	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—lung cancer	1.55e-05	0.000338	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB2—lung cancer	1.53e-05	0.000335	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTOR—lung cancer	1.51e-05	0.00033	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—lung cancer	1.51e-05	0.00033	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—lung cancer	1.51e-05	0.00033	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—lung cancer	1.51e-05	0.000329	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EP300—lung cancer	1.47e-05	0.000322	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—lung cancer	1.47e-05	0.00032	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—lung cancer	1.45e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—lung cancer	1.44e-05	0.000315	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—lung cancer	1.43e-05	0.000313	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—lung cancer	1.43e-05	0.000313	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—lung cancer	1.4e-05	0.000307	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—lung cancer	1.4e-05	0.000305	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—lung cancer	1.39e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—lung cancer	1.39e-05	0.000303	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—lung cancer	1.38e-05	0.000302	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—lung cancer	1.38e-05	0.000302	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRAS—lung cancer	1.38e-05	0.000301	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—lung cancer	1.35e-05	0.000296	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—lung cancer	1.35e-05	0.000296	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUN—lung cancer	1.35e-05	0.000295	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.32e-05	0.000289	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—lung cancer	1.31e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.31e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—lung cancer	1.31e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—lung cancer	1.28e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.27e-05	0.000279	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—lung cancer	1.26e-05	0.000275	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EP300—lung cancer	1.25e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.24e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—lung cancer	1.21e-05	0.000265	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—lung cancer	1.2e-05	0.000263	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—lung cancer	1.19e-05	0.000259	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.18e-05	0.000258	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—lung cancer	1.17e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRAS—lung cancer	1.17e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—lung cancer	1.15e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.12e-05	0.000244	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—lung cancer	1.1e-05	0.000241	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.09e-05	0.000238	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—lung cancer	1.09e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—lung cancer	1.06e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—lung cancer	1.06e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—lung cancer	1.02e-05	0.000222	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—lung cancer	1.01e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—lung cancer	1e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—lung cancer	9.66e-06	0.000211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—lung cancer	9.22e-06	0.000201	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—lung cancer	8.92e-06	0.000195	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—lung cancer	8.91e-06	0.000195	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—lung cancer	8.53e-06	0.000186	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—lung cancer	8.16e-06	0.000178	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—lung cancer	7.53e-06	0.000165	CbGpPWpGaD
